Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 8,300 | 8,125 | 7,315 | 7,369 | 6,932 |
| Operating Income | -8,300 | -8,125 | -7,315 | -7,369 | -6,932 |
| Interest Expense | 114 | 137 | 168 | 185 | 196 |
| Other Income | 353 | 438 | 471 | 415 | 333 |
| Pre-tax Income | -8,061 | -7,824 | -7,012 | -7,139 | -6,795 |
| Income Tax | N/A | N/A | 1 | N/A | N/A |
| Net Income Continuous | -8,061 | -7,824 | -7,013 | -7,139 | -6,795 |
| Net Income | $-8,061 | $-7,824 | $-7,013 | $-7,139 | $-6,795 |
| EPS Basic Total Ops | -0.39 | -0.40 | -0.37 | -0.42 | -0.40 |
| EPS Basic Continuous Ops | -0.39 | -0.40 | -0.37 | -0.42 | -0.39 |
| EPS Diluted Total Ops | -0.39 | -0.40 | -0.37 | -0.42 | -0.40 |
| EPS Diluted Continuous Ops | -0.39 | -0.40 | -0.37 | -0.42 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -0.40 | -0.37 | N/A | N/A |
| EBITDA(a) | $-8,274 | $-8,120 | $-7,268 | $-7,377 | $-7,032 |